Today: 20 March 2026
Subscribe
Browse Category

NASDAQ:ARCT 22 October 2025

Arcturus Therapeutics Stock Soars to New High Then Crashes on Trial Data – What Investors Need to Know

Arcturus Therapeutics Stock Soars to New High Then Crashes on Trial Data – What Investors Need to Know

Arcturus stock hit a 52-week high of $24.17 on Oct. 21 before plunging up to 60% after mixed Phase 2 cystic fibrosis trial results. Interim data showed ARCT-032 was generally safe and reduced lung mucus in most patients, but failed to improve primary lung-function measures. A higher-dose cohort is underway. Analyst ratings remain moderately positive, with price targets averaging $50.
22 October 2025
·

Stock Market Today

  • Dollar Strengthens Amid Iran War and Hawkish Central Bank Signals
    March 20, 2026, 5:48 PM EDT. The dollar index rose 0.42% on Friday driven by stock market weakness and heightened demand as a safe haven amid the ongoing war in Iran. Higher U.S. Treasury note yields boosted interest rate differentials supporting the greenback. Fed Chair Powell's recent remarks signaled no rate cuts without inflation progress, influencing market expectations for the April FOMC meeting. The euro fell 0.31%, pressured by a stronger dollar, a steep drop in German producer prices, and rising oil costs impacting the Eurozone. ECB officials hinted at possible rate hikes. The yen dropped over 1% amid dollar gains and rising yields, worsened by surging oil prices affecting Japan's energy imports. Precious metals including gold and silver declined on a stronger dollar and higher global bond yields, with hawkish central bank stances stemming from energy cost surges linked to the Iran conflict.
Go toTop